The Journal of nutrition · 2025
Inflammatory Cytokine Responses to 6 Wks of Increased Dairy Intake in Individuals with Overweight and Obesity-A Randomized Crossover Trial.
СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Prowting Joel L, Fraschetti Emily C, Pereira Tania J, Tucker Jessica Al, Gagnon Sara, Cheng Nicholas, Edgell Heather, Wright David C, Klentrou Panagiota, Perry Christopher Gr, Josse Andrea R
Аннотация
BACKGROUND: Dairy products are important sources of macro/micronutrients and contain bioactive components with anti-inflammatory, antioxidant, and musculoskeletal supporting properties. Few studies have assessed the short-term effect of consuming a variety of wholefood dairy products (as opposed to single foods/nutrients) on a range of interrelated inflammatory, metabolic, antioxidant and vascular outcomes.
OBJECTIVES: To compare these physiological outcomes after 6 wks of a high mixed-dairy diet compared with 6 wks of a low dairy diet.
METHODS: Using a randomly assigned crossover design, 30 adults (18 females/12 males) with overweight/obesity (OW/OB) (BMI: 32.0 ± 4.5 kg/m2] and pre-existing cardiometabolic disease risk factors completed two 6-wk dietary intervention conditions in random order (separated by a ≥4-wk washout); 1) a high-dairy (HD) diet (3 servings/d of a mix of low-fat milk, Skyr yogurt, full-fat cheddar cheese) and 2) their habitually low-dairy (LD) diet (≤1 serving/d). At baseline and then 6 wks later, fasted blood samples were collected, body composition was assessed, and vascular measurements were taken.
RESULTS: After controlling for age, BMI, sequence and period, there were no condition∗time interactions for interleukin-6 (IL-6; primary endpoint); however, there were condition∗time interactions for tumor necrosis factor-alpha (TNF-α; P = 0.042), and IL-4 (P = 0.026) such that they decreased and increased, respectively, on the HD diet compared with the LD diet. No other condition∗time interactions were observed for the other outcomes but we did observe sex∗condition interactions for IL-6 (P = 0.011), TNF-α (P < 0.001), triglycerides (P = 0.014), and diastolic blood pressure (P = 0.045), which were higher during the HD condition in males.
CONCLUSIONS: Increasing mixed dairy product intake for 6 wks favorably modulated some cytokines in the absence of metabolic, vascular, body weight, or fat changes. Differences in biomarker concentrations in relation to dairy intake and/or exercise may also be influenced by sex; however, this should be further explored. Overall, increased dairy intake may help ameliorate inflammation in individuals with OW/OB and cardiometabolic dysfunction. This trial was registered at clinicaltrials.gov as NCT04902417.
OBJECTIVES: To compare these physiological outcomes after 6 wks of a high mixed-dairy diet compared with 6 wks of a low dairy diet.
METHODS: Using a randomly assigned crossover design, 30 adults (18 females/12 males) with overweight/obesity (OW/OB) (BMI: 32.0 ± 4.5 kg/m2] and pre-existing cardiometabolic disease risk factors completed two 6-wk dietary intervention conditions in random order (separated by a ≥4-wk washout); 1) a high-dairy (HD) diet (3 servings/d of a mix of low-fat milk, Skyr yogurt, full-fat cheddar cheese) and 2) their habitually low-dairy (LD) diet (≤1 serving/d). At baseline and then 6 wks later, fasted blood samples were collected, body composition was assessed, and vascular measurements were taken.
RESULTS: After controlling for age, BMI, sequence and period, there were no condition∗time interactions for interleukin-6 (IL-6; primary endpoint); however, there were condition∗time interactions for tumor necrosis factor-alpha (TNF-α; P = 0.042), and IL-4 (P = 0.026) such that they decreased and increased, respectively, on the HD diet compared with the LD diet. No other condition∗time interactions were observed for the other outcomes but we did observe sex∗condition interactions for IL-6 (P = 0.011), TNF-α (P < 0.001), triglycerides (P = 0.014), and diastolic blood pressure (P = 0.045), which were higher during the HD condition in males.
CONCLUSIONS: Increasing mixed dairy product intake for 6 wks favorably modulated some cytokines in the absence of metabolic, vascular, body weight, or fat changes. Differences in biomarker concentrations in relation to dairy intake and/or exercise may also be influenced by sex; however, this should be further explored. Overall, increased dairy intake may help ameliorate inflammation in individuals with OW/OB and cardiometabolic dysfunction. This trial was registered at clinicaltrials.gov as NCT04902417.